ECA
PETS icon

Elevated Capital Advisors’s PetMed Express PETS Stock Holding History

Elevated Capital Advisors’s Portfolio PETS Stock Details PETS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$114 Hold
50
– – ﹤0.01% 834
2025
Q4 		$160 Buy
+50
New +$125 ﹤0.01% 815

Other funds holding PETS

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SPH
Steel Partners Holdings New York $96.4M AUM
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return

Elevated Capital Advisors's PETS Position: Q1 2026 in Review

Elevated Capital Advisors held its PetMed Express (PETS) position steady in Q1 2026 at 50 shares worth $114. The position accounts for ﹤0.01% of the portfolio, ranked #834.

Elevated Capital Advisors first reported a position in PETS in Q4 2025 and has held it in 2 quarters since. The position peaked at $160 in Q4 2025. 49 funds tracked by Wall St. Rank hold PETS as of Q1 2026.

  • Elevated Capital Advisors held 50 shares of PetMed Express worth $114 as of Q1 2026.
  • Elevated Capital Advisors left its PetMed Express share count unchanged in Q1 2026.
  • PetMed Express made up ﹤0.01% of Elevated Capital Advisors's portfolio in Q1 2026, its #834 holding.
  • Elevated Capital Advisors first reported a position in PetMed Express in Q4 2025 and has held it in 2 quarters since.
  • Elevated Capital Advisors's PetMed Express position peaked at $160 in Q4 2025.
  • 49 funds tracked by Wall St. Rank held PetMed Express as of Q1 2026.

Based on Elevated Capital Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.